Skip to main content
Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
11.25
-0.34 (-2.93%)
At close: Nov 22, 2024, 4:00 PM
11.33
+0.08 (0.71%)
After-hours: Nov 22, 2024, 7:20 PM EST

Evolent Health Revenue

Evolent Health had revenue of $621.40M in the quarter ending September 30, 2024, with 21.60% growth. This brings the company's revenue in the last twelve months to $2.46B, up 37.65% year-over-year. In the year 2023, Evolent Health had annual revenue of $1.96B with 45.26% growth.

Revenue (ttm)
$2.46B
Revenue Growth
+37.65%
P/S Ratio
0.52
Revenue / Employee
$524,309
Employees
4,700
Market Cap
1.29B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.96B611.88M45.26%
Dec 31, 20221.35B444.06M48.91%
Dec 31, 2021907.96M-16.68M-1.80%
Dec 31, 2020924.64M237.52M34.57%
Dec 31, 2019687.12M60.06M9.58%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.26B
Indivior 1.18B
MiMedx Group 342.80M
STAAR Surgical Company 341.22M
Arcus Biosciences 263.00M
Day One Biopharmaceuticals 101.95M
Ocular Therapeutix 61.44M
Syndax Pharmaceuticals 16.00M
Revenue Rankings

EVH News

More News